Xerostomia Therapeutics Market size was valued at USD 2.14 billion in 2024 and is set to exceed USD 3.52 billion by 2037, expanding at over 3.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of xerostomia therapeutics is evaluated at USD 2.21 billion.
The increase in adoption of radiation therapy and chemotherapy is likely to lead to an increased incidence of xerostomia, which is estimated to predominantly drive the xerostomia therapeutics market. Other factors driving the market growth include increasing usage of prescription medicines, easy availability and cost-effectiveness of medicines, growing geriatric population base and increasing prevalence of diseases, such as Sjogren’s syndrome, HIV, diabetes, and Alzheimer’s disease, among other diseases. According to the Centres for Disease Control & Prevention (CDC), every year about 650,000 cancer patients receive chemotherapy in an outpatient oncology clinic.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
3.9% |
|
Base Year Market Size (2024) |
USD 2.14 billion |
|
Forecast Year Market Size (2037) |
USD 3.52 billion |
|
Regional Scope |
|
The market is segmented based on product into artificial saliva, salivary stimulants, saliva substitutes, drugs, salivary pens and others, out of which, the salivary stimulants segment is anticipated to grab the largest share by the end of 2037 on account of being available in various forms such as mints, sugar-free chewing gums, sprays and mores. A wide range of substitutes for each product is easily available and accessible to patients, thus is expected to drive the growth of the segment.
On the basis of distribution channel, the retail pharmacies and hospital pharmacies segments in the global xerostomia therapeutics market are projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the presence of retail and hospital pharmacies, serving to a larger customer base. Moreover, the online pharmacy segment is estimated to grow at a higher rate during the forecast period due to growing internet penetration in developing countries and changing trends of ordering medicine online.
Our in-depth analysis of the global market includes the following segments
|
By Product |
|
|
By Distribution Channel |
|
North America Market Statistics
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. North America industry is set to account for largest revenue share by 2037, due to prominent growth of cases in xerostomia as well as various other diseases associated with dry mouths such as rheumatoid arthritis, HIV, and Sjogren's syndrome. Sjogren Syndrome Foundation frequently carries out awareness camps regarding the therapies and remedies for the people with xerostomia across U.S. and Canada. Furthermore, expanding medical and healthcare infrastructure, ease of availability of treatments, and beneficial compensation scenario are some of the important factors which are helping the market to grow in the North American region.
APAC Market Analysis
Asia Pacific’s market is expected to gain traction and is expected to grow at a faster rate during the forecast period. Increased spending towards healthcare, growing understanding and awareness about chronic diseases are anticipated to strengthen the market in the Asia Pacific.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?